ILIAS is a biotechnology company that develops and commercializes exosome-based therapeutics for the treatment of inflammatory and metabolic diseases.
Business Model:
Revenue: $4.9M
Employees: 11-50
Address: 40-20 Techno 6-ro,
City: Daejeon
State: daejeon gwang'yeogsi
Zip: 34014
Country: KR
ILIAS is a biotechnology company that develops and commercializes exosome-based therapeutics for the treatment of inflammatory and metabolic diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Series B | $0 |
Asset One Daedeok Venture Partners Daishin Securities Devsisters Ventures Genie Asset Management Hanyang Securities HB Investment Kiwoom Investment Meritz Securities Time Folio Asset Management Asset One Daedeok Venture Partners Daishin Securities Devsisters Ventures Genie Asset Management Hanyang Securities HB Investment Kiwoom Investment Meritz Securities Time Folio Asset Management |
5/2018 | Series A | $17M | 11/2019 | Unattributed | $1.5M | 9/2016 | Angel | - | 9/2020 | Series B | 10 | $20.6M |
Asset One Devsisters Ventures Meritz Securities Kiwoom Securities Daishin Securities Hanyang Securities HB Investment Timefolio Asset Management Daedeok Venture Partners Asset One Daedeok Venture Partners Daishin Securities Devsisters Ventures Genie Asset Management Hanyang Securities HB Investment Kiwoom Investment Meritz Securities Time Folio Asset Management |
3/2019 | Grant | - | 9/2016 | Angel | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|